Faculty of Veterinary Medicine, Department of Physiology, University of Tehran, Tehran, Iran.
Neuroscience Research Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Neurochem Res. 2021 Mar;46(3):648-659. doi: 10.1007/s11064-020-03199-5. Epub 2021 Jan 3.
Sensitization to psychostimulant drugs, as well as morphine, subjected to cross-sensitization with stress. The development of morphine sensitization is associated with enhancements in dopamine overflow in the Nucleus accumbens (NAc). This study aimed to examine the role of accumbal D1/D2-like dopamine receptors in restraint stress (RS) induced sensitization to morphine antinociceptive effects. Adult male Wistar rats weighing 220-250 g underwent stereotaxic surgery. Two stainless steel guide cannulae were bilaterally implanted, 1 mm above the NAc injection site. Different solutions of SCH-23390, as a D1-like receptor antagonist or sulpiride, as a D2-like receptor antagonist, were microinjected into the NAc five min before exposure to RS. Restraint stress lasted for 3 h, 10 min after RS termination; animals received a subcutaneous injection of morphine (1 mg/kg) for 3 consecutive days. The procedure was followed by a 5-day drug and/or stress-free period. After that, on the 9th day, the nociceptive response was evaluated by the tail-flick test. The results revealed that intra-NAc administration of D1/D2-like dopamine receptor antagonists, SCH-23390 or sulpiride, respectively, blocked morphine sensitization-induced by RS and morphine co-administration in rats for three consecutive days. This work provides new insight into the determinant role of accumbal dopamine receptors in morphine sensitization produced by RS-morphine co-administration.
药物敏化作用,以及吗啡,会受到交叉敏化作用的影响,如应激。吗啡敏化的发展与伏隔核(NAc)中多巴胺溢出的增强有关。本研究旨在探讨伏隔核 D1/D2 样多巴胺受体在束缚应激(RS)诱导吗啡镇痛作用敏化中的作用。成年雄性 Wistar 大鼠体重 220-250 克,行立体定向手术。将两个不锈钢引导套管双侧植入,位于 NAc 注射部位上方 1 毫米处。SCH-23390(D1 样受体拮抗剂)或舒必利(D2 样受体拮抗剂)的不同溶液在暴露于 RS 前 5 分钟被微注射到 NAc 中。束缚应激持续 3 小时,RS 结束后 10 分钟;动物接受皮下注射吗啡(1mg/kg)连续 3 天。该程序后是 5 天的药物和/或无应激期。之后,在第 9 天,通过尾巴闪烁试验评估痛觉反应。结果表明,分别向 NAc 内注射 D1/D2 样多巴胺受体拮抗剂 SCH-23390 或舒必利,可阻断 RS 与吗啡连续 3 天共给药引起的吗啡敏化。这项工作为 RS-吗啡共给药引起的吗啡敏化中伏隔核多巴胺受体的决定作用提供了新的见解。